higenamine has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ling, W; Wu, MP; Xue, C; Yan, C; Zhang, YS; Zhou, Z; Zhu, JX | 1 |
| Liu, XJ; Tao, S; Wagner, HN | 1 |
2 other study(ies) available for higenamine and Cardiac Diseases
| Article | Year |
|---|---|
Higenamine attenuates cardiac fibroblast abstract and fibrosis via inhibition of TGF-β1/Smad signaling.
Topics: Actins; Adrenergic beta-Agonists; Alkaloids; Animals; Aorta; Apoptosis; Cardiomegaly; Fibrinolytic Agents; Fibroblasts; Fibrosis; Heart Diseases; Hypertension; Isoproterenol; Mice; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Tetrahydroisoquinolines; Transforming Growth Factor beta1 | 2021 |
Measurement of effects of the Chinese herbal medicine higenamine on left ventricular function using a cardiac probe.
Topics: Adult; Alkaloids; Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Diseases; Heart Rate; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Stroke Volume; Tetrahydroisoquinolines | 1983 |